This session will explore recent trends in valuing businesses and intellectual property in the cannabis industry. Appraisers often apply market-based metrics to historical data when performing traditional valuations. In the cannabis industry, history is not often indicative of the future and reliance on historical data may lead to inaccurate valuations. The value of businesses in established markets like Colorado, Oregon, and Washington is different than the value of businesses in newly legal states or those anticipated to become legal in the near future. When multi-state operators pay premiums to get into states, does it represent fair market value or strategic value? This session will address these topics along with valuing brands, the impact, and treatment of IRC 280E in an appraisal context, and where to find industry data and resources.
After attending this session, attendees will be able to:
In 2020-2021, government stimulus programs, foreclosure moratoria and relaxed banking regulations helped many insolvent companies survive through the COVID pandemic. As these programs expire, will we see a bankruptcy pandemic? This session will discuss trends in financial restructurings, options available to insolvent companies, and what industries are at most risk.
After attending this session, attendees will be able to:
The healthcare regulatory environment has been in a state of constant flux since the start of the COVID-19 pandemic. The pandemic has resulted in numerous temporary regulatory changes that many in the legal industry believe may become permanent. Further, the federal government has taken (or indicated their intention to take) additional steps not related to COVID that impact the healthcare delivery system. This session will provide a review of the current healthcare legal landscape and discuss recent healthcare regulatory developments that affect our valuation engagements, such as:
This session will conclude with a discussion of the valuation implications of these various developments.